Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen-arginine premedication for mandibular block success in symptomatic pulpitis
RBR-6z4jrs8Phase 3Completed
- Sponsor
- Universidade Federal de Goiás
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pulpitis comparing Ibuprofen, Ibuprofen arginine and Placebo control (3 arms). Primary endpoint: Anesthetic block success. Started Mar 2022; status: completed.
02
Drugs
ibuprofenibuprofen arginine
03
Conditions
pulpitis
Beyond the preview
Go deeper on RBR-6z4jrs8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6z4jrs8.